Analyst firms · Piper Sandler · ARDX
Piper Sandler ARDX price target and rating history
Ardelyx Inc. (ARDX) · Health Care
Piper Sandler rates Ardelyx Inc. (ARDX) Overweight with a $7 price target, as of its latest action on Jan 9, 2026. It has published 4 rating actions on ARDX since July 2021, including 2 upgrades and 2 downgrades.
- Current rating
- Overweight
- Price target
- $7
- Median target, all firms
- Too few
- Actions on ARDX
- 4
Piper Sandler price target on ARDX
Every Piper Sandler rating on ARDX
- Jan 9, 2026
- Jul 2, 2024
- Nov 17, 2022
- Jul 20, 2021
How other firms rate ARDX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Ladenburg Thalmann | Buy | $16 | Jun 16, 2026 |
| Piper Sandler | Overweight | Jan 9, 2026 |
Questions about Piper Sandler and ARDX
- What is Piper Sandler's price target for ARDX?
- Piper Sandler's latest stated price target for Ardelyx Inc. (ARDX) is $7, from its action on Jul 2, 2024.
- What is Piper Sandler's rating on ARDX?
- Piper Sandler rates ARDX Overweight, a bullish rating, as of Jan 9, 2026.
- When did Piper Sandler last change its view on ARDX?
- On Jan 9, 2026, Piper Sandler upgrades to Overweight from Neutral.
More ARDX rating histories
All Piper Sandler ratingsARDX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.